Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Katerina Gurova
AKT2 Is Frequently Upregulated in HER-2/neu-positive Breast Cancers and May Contribute to Tumor Aggressiveness by Enhancing Cell Survival
Oncogene
Cancer Research
Genetics
Molecular Biology
Related publications
Impact of Polysomy 17 on HER-2/neu Immunohistochemistry in Breast Carcinomas Without HER-2/neu Gene Amplification
Journal of Molecular Diagnostics
Forensic Medicine
Pathology
Molecular Medicine
Dystroglycan Expression Is Frequently Reduced in Human Breast and Colon Cancers and Is Associated With Tumor Progression
American Journal of Pathology
Forensic Medicine
Pathology
Hormone Receptors, Her-2/Neu and Chromosomal Aberrations in Breast Cancer
Medical Journal Armed Forces India
Medicine
Amplification of Her-2/Neu Gene in Her-2/Neu-Overexpressing and -Nonexpressing Breast Carcinomas and Their Synchronous Benign, Premalignant, and Metastatic Lesions Detected by FISH in Archival Material
Modern Pathology
Forensic Medicine
Pathology
Immunohistochemical Evaluation of Her-2/Neu Overexpression in Breast Carcinoma in Mosul
Annals of the College of Medicine, Mosul
Treatment of HER-2/neu Overexpressing Breast Cancer Xenograft Models With Trastuzumab (Herceptin) and Gefitinib (ZD1839): Drug Combination Effects on Tumor Growth, HER-2/neu and Epidermal Growth Factor Receptor Expression, and Viable Hypoxic Cell Fraction
Clinical Cancer Research
Cancer Research
Oncology
Reduction in HER-2 Protein Expression in a Breast Tumor HER-2 Positive After Only One Injection of Trastuzumab: A Case Report
Cases Journal
Chemosensitization of HER-2/neu-overexpressing Human Breast Cancer Cells to Paclitaxel (Taxol) by Adenovirus Type 5 E1A
Oncogene
Cancer Research
Genetics
Molecular Biology
Comparison of the Efficacy and Survival Analysis of Neoadjuvant Chemotherapy for Her-2-Positive Breast Cancer
Drug Design, Development and Therapy
Drug Discovery
Pharmacology
Pharmaceutical Science
